Lang has over 20 years of executive experience in the biotechnology industry and most recently served as the vice president of business development at Aldevron LLC, a custom producer of nucleic acids, proteins, and antibodies.
The new executive will be responsible for ImmunoPrecise Antibodies' corporate and business development activities as well as corporate and product strategic planning.
“(Dr Lang) brings an impressive breadth of leadership expertise in the biotech industry, including experience working at the organizational level and as a globally-recognized and respected leader in antibody business development," said Dr Jennifer Bath, CEO of ImmunoPrecise in a statement.
"We look forward to Dr. Lang's insightful contributions as we pursue our mission of transforming next generation antibody therapeutics and diagnostics."
Lang said he was “thrilled” to join the Victoria-based company. "In only a few years, ImmunoPrecise has established itself as a leader in the antibody discovery space, with a clear vision and the technical capabilities to become the preferred partner of choice for this industry."
“I see tremendous opportunity to build on this progress and I am eager to lend my expertise to ImmunoPrecise as the partner-of-choice for biopharmaceutical companies pursuing antibody discovery in immunotherapies and diagnostics,” he added.
Contact Angela at firstname.lastname@example.org
Follow her on Twiiter @AHarmantas